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ABSTRACT: DNA oxidation damage has been regarded as one
of the possible mechanisms for the hepatic carcinogenesis of
dioxin-like compounds (DLCs). In this study, we evaluated the
toxic equivalency factor (TEF) from the standpoint of induced
DNA oxidation products and their relationship to toxicity and
carcinogenicity. Nine DNA oxidation products were analyzed in
the liver of female Sprague−Dawley rats exposed to 2,3,7,8-
tetrachlorodibenzo-pdioxin (TCDD) alone or the tertiary
mixture of TCDD, 3,3′,4,4′,5-pentachlorobiphenyl (PCB 126),
and 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) by gavage for
14, 31, and 53 weeks (5 days/week) by LC−MS/MS: 8-oxo-7,8-
dihydro-2′-deoxyguanosine (8-oxo-dGuo); 1,N6-etheno-2′-deoxyadenosine (1,N6-εdAdo); N2,3-ethenoguanine (N2,3-εG); 7-(2-
oxoethly)guanine (7-OEG); 1,N2-etheno-2′-deoxyguanosine (1,N2-εdGuo); malondialdehyde (M1dGuo); acrolein (AcrdGuo);
crotonaldehyde (CrdGuo); and 4-hydroxynonenal (HNEdGuo) derived 2′-deoxyguanosine adducts. Exposure to TCDD (100
ng/kg/day) significantly induced 1,N6-εdAdo at 31 and 53 weeks, while no increase of 8-oxo-dGuo was observed. Significant
increases were observed for 8-oxo-dGuo and 1,N6-εdAdo at all time points following exposure to the tertiary mixture (TEQ 100
ng/kg/day). Exposure to TCDD for 53 weeks only significantly increased 1,N6-εdAdo, while increases of N2,3-εG and 7-OEG
were only found in the highest dose group (100 ng/kg/day). Exposure to the tertiary mixture for 53 weeks had no effect on N2,3-
εG in any exposure group (TEQ 0, 22, 46, or 100 ng/kg/day), while significant increases were observed for 1,N6-εdAdo (all dose
groups), 8-oxo-dGuo (46 and 100 ng/kg/day), and 7-OEG (100 ng/kg/day). While no significant increase was observed at 53
weeks for 1,N2-εdGuo, M1dGuo, AcrdGuo, or CrdGuo following exposure to TCDD (100 ng/kg/day), all of them were
significantly induced in animals exposed to the tertiary mixture (TEQ 100 ng/kg/day). This oxidation DNA product data suggest
that the simple TEF methodology cannot be applied to evaluate the diverse patterns of toxic effects induced by DLCs.
■ INTRODUCTION
Oxidative stress, a common state in pathophysiology, occurs
when the number of reactive oxygen species (ROS) being
formed is exceeded by those being detoxified. Many
endogenous processes, as well as exogenous chemicals or
their metabolites, are known to produce ROS. Besides ROS,
reactive nitrogen species (RNS) are also generated by
macrophages and neutrophils involved in chronic inflammation,
which has been recognized as a risk factor in many human
cancers.1 These species or their active metabolites can interact
with cellular constituents, especially lipids or nucleic acids, and
further induce various DNA oxidation products.2 These DNA
lesions have been implicated in aging, neurodegeneration, and a
myriad of diseases including cancer.2 To date, there are several
key ROS/RNS-induced DNA oxidation products: 8-oxo-7,8-
dihydro-2′-deoxyguanosine (8-oxo-dGuo); 1,N6-etheno-2′-de-
oxyadenosine (1,N6-εdAdo); 3,N4-etheno-2′-deoxycytidine
(3,N4-εdC); N2,3-ethenoguanine (N2,3-εG); 1,N2-etheno-2′-
deoxyguanosine (1,N2-εdGuo); and malondialdehyde (MDA),
acrolein, crotonaldehyde, and 4-hydroxynonenal (HNE)
derived 2′-deoxyguanosine (dGuo) adducts, designated as
M1dGuo, AcrdGuo, CrdGuo, and HNEdGuo, respectively.
3−7
Among them, the most studied adduct, 8-oxo-dGuo, is formed
in relatively high amounts in vivo with steady-state levels
usually around 1/106 guanine. It is formed directly by the
reaction between dGuo and ROS or carbonate anion radical
induced by RNS.1,8 ROS and RNS metabolites can also abstract
hydrogen atoms from polyunsaturated fatty acids producing
lipid peroxides and many reactive byproducts such as MDA,
HNE, crotonaldehyde, and acrolein. These compounds can
further damage DNA and generate multiple oxidation DNA
products, which include exocyclic products with either a five-
member (etheno products) or a six-member (propano
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products) ring attached to DNA bases, as depicted in Figure
1.1,3−7 Recently, 7-(2-oxoethly)guanine (7-OEG) has been
identified as a new DNA product formed by lipid peroxidation
(LPO) with steady-state levels around 1−10 adduct/106
guanine.9 In addition to these distinct formation pathways,
site-directed mutagenicity studies found that most of these
DNA products can induce specific transition or transversion
point mutations in bacteria or mammalian cells.8,10−12 7-OEG
can induce apurinic/apyrimidinic sites (AP sites) in biological
systems, although it has no miscoding properties.9 Considering
the diverse metabolic pathways and the mutation spectrum
induced by those important ROS/RNS-induced DNA prod-
ucts, evaluating their profile data could compensate for biased
results induced by a single product. Growing evidence also
indicates that these DNA lesions are significantly induced in
patients and animals with various chronic inflammatory diseases
including certain cancers.3,7,8,13,14 Although DNA oxidation
product formation is generally regarded as a key event for the
carcinogenesis of genotoxic chemicals, it may also be a
significant contributor for the tumorigenesis of nongenotoxic
chemicals, especially chemicals capable of enhancing the
formation of endogenous active metabolites, RNS and ROS,
such as polyha logenated aromat ic hydrocarbons
(PHAHs).15−20
PHAHs comprise a large class of compounds such as
polychlorinated dibenzodioxins (PCDDs), polychlorinated
dibenzofurans (PCDFs), and polychlorinated biphenyls
(PCBs).21−24 While PHAHs are regarded as one of the most
prevalent groups of pollutants in the environment due to
industrial use, PCDDs and PCDFs are also produced as
byproducts during anthropogenic activities such as chlorine
bleaching of paper and combustion of wastes and fuels.21−23
PCBs were commercially produced and widely used for various
industrial purposes including heat transfer agents, dielectric
insulating fluids for capacitors and transformers, plasticizers,
and paint additives.24 Because of PHAHs’ resistance to
degradation and persistence in environment, their ability to
bioaccumulate in humans and wildlife animals may result in
chronic lifetime exposure, possible toxicity, and carcinogenic-
ity.21−24 Depending on the location and type of halogenations,
some PHAHs induce a similar spectrum of biochemical and
toxic responses in experimental animals. These responses are
considered to be mediated through a common mechanism of
action initiated by binding to a cytosolic receptor known as the
aryl hydrocarbon receptor (AhR) and triggering the expression
of a variety of genes, the so-called AhR gene battery.21
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), commonly
referred to as “dioxin”, is the prototype of these structurally
related compounds and exhibits the highest potency of binding
to the AhR. Hence, these structurally related compounds are
commonly referred to as dioxin-like compounds (DLCs).
Because of similarities in toxicity, the concept of the toxic
equivalency factor (TEF) has been applied for the risk
assessment and regulatory control for DLCs.25 Therefore, the
toxicity of PHAH mixtures is expressed in terms of its total
toxic equivalent quotient (TEQ), which is the amount of
TCDD that would produce the equal toxic effect of all
contributing congeners within the mixture. This allows for the
estimation of the potential dioxin-like activity of PHAH
mixtures in the environment.
Figure 1. Illustration of the major DNA adducts induced by ROS/RNS.
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The association of oxidative stress and PHAHs, especially
TCDD, has been studied for several decades.17−19,26−39
Substantial evidence has accumulated to support that TCDD
can induce oxidative stress in mammalian cells in vitro and in
rodents in vivo. Different biomarkers have been applied to
assess the oxidative stress induced by TCDD in the liver of
animals including hepatic LPO, DNA single strand breaks,
hepatic membrane fluidity, glutathione, nonprotein sulfhydryl,
and NADPH.30,31 Significantly increased LPO with large strain
differences has also been detected in other organs of rats and
mice exposed to TCDD including kidney, thymus, heart, testes,
and brain. Similarly, PCB-induced oxidative stress was also
observed in numerous studies.17,20,26−29,32−36,38,39 These
studies indicate that oxidative stress is a ubiquitous side effect
produced by these compounds. Although many PHAHs have
been shown to have very weak initiating activity without direct
genotoxic effects, it has been postulated that they may be
indirectly genotoxic through the formation of DNA lesions
induced by ROS and RNS.15,17−20,26−39 Because the TEF has
been widely applied for the evaluation of the toxic effects of
PHAHs and oxidative stress is universally induced in the
animals exposed to these compounds, it is meaningful to
evaluate the application of the TEF approach in the toxicity of
PHAHs using DNA oxidation products, especially in chronic
animal carcinogenesis studies.
Several PHAHs were chosen by the National Toxicology
Program (NTP) as model compounds including TCDD, PCB
126, and 2,3,4,7,8-pentachlorodibenzofuran (PeCDF).21−24
PCB 126 is a non-ortho-substituted PCB with a TEF value of
0.1. As the most potent DLC in the environment, PCB 126
accounts for 40−90% of the toxic potency of dioxin-like
PCBs.22 PeCDF, with a TEF value of 0.5, represents the most
potent PCDF present in human tissues.23 The structures of
these compounds are shown in Figure 2. An important
assumption for the TEF methodology is that the toxicity of a
mixture of DLCs is dose additive based on the TEF value of the
individual components. This study has evaluated this
assumption from the standpoint of the number of induced
DNA oxidation products and their relationship to toxicity and
carcinogenicity of PHAHs.
In this study, we collaborated with the NTP to understand
the DNA oxidation product profile in hepatic DNA of female
Sprague−Dawley rats that were exposed to TCDD and the
tertiary mixture of TCDD, PCB 126, and PeCDF (Figure 2) for
14, 31, and 53 weeks. Nine DNA oxidation lesions (7-OEG; 8-
oxo-dGuo; 1,N6-εdAdo; 1,N2-εdGuo; N2,3-εG; M1dGuo;
AcrdGuo; CrdGuo; HNEdGuo) were measured in hepatic
DNA isolated from female Sprague−Dawley rats. Since each
product has distinct metabolic pathways in vivo, our assessment
of a battery of DNA oxidation lesions provides extensive
information on DNA oxidation damage. This knowledge
enables us to better estimate the toxicity of PHAHs and
improve the scientific basis of human risk assessment of
PHAHs in the environment.
■ EXPERIMENTAL PROCEDURES
Chemicals. Nucleic acid purification grade lysis buffer, protein
precipitation solution, and proteinase K were purchased from Gentra
Systems (Minneapolis, MN). HPLC-grade water and methanol were
from Thermo Fisher Scientific Company (Raleigh, NC). 15N5-8-Oxo-
dGuo, 15N5-dGuo, and
13C10-dGuo were purchased from Cambridge
Isotope Laboratories (Andover, MA, USA). Other chemical reagents
were from Sigma-Aldrich Chemical Co. (St. Louis, MO). 15N5-1,N
6-
εdAdo standard was synthesized as described by Ham et al.40 1,N2-
εdGuo and 13C10-1,N
2-εdGuo were synthesized as reported by
Kusmierek et al.41 MDA modified 15N5 and
14N5 DNA were made
using the method in Jeong’s study.42 AcrdGuo, CrdGuo, and
HNEdGuo standards and their 15N5 labeled internal standards were
synthesized according to previous studies.43−45 7-OEG, 15N5-7-OEG,
and N2,3-εG were synthesized as described previously by Mutlu et
al.9,46
Animal Exposure and DNA Isolation. Rat liver tissues were
provided by Battelle Laboratories (Columbus, OH) and State
University of New York at Buffalo, which conducted the studies
under NIEHS contract (N01-ES-75411).21−24 Female Sprague−
Dawley rats were exposed to either TCDD alone or the tertiary
mixture by gavage 5 days per week for 14, 31, and 53 weeks. The doses
used for TCDD were 0 and 100 ng/kg/day for 14, 31, 53 weeks; 0, 22,
46, and 100 ng/kg/day for 53 weeks. The TEQ doses used for the
tertiary mixture were 0 and 100 ng/kg/day for 14, 31, 53 weeks; 0, 22,
46, and 100 ng/kg/day for 53 weeks. Further explanation of the TEQ
doses can be found in the NTP technical report on the toxicology and
carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) (Cas No. 1746−01−6), 2,3,4,7,8-pentachloro-
dibenzofuran (PeCDF) (Cas No. 57117−31−4), and 3,3′,4,4′,5-
pentachlorobiphenyl (PCB 126) (Cas No. 57465−28−8) in female
Harlan Sprague−Dawley rats (gavage studies).24 Liver tissues were
collected from 4−8 female rats per group/day after the final exposure
and stored frozen at −80 °C. DNA was isolated as described
previously.46
8-Oxo-dGuo and 1,N6-εdAdo Assay. The assay was performed
as previously described by Pang et al.7 with minor modifications. A 100
μg sample of DNA in NaOAc buffer I (sodium acetate 30 mM, 0.2
mM ZnCl2, pH 5.6) was incubated with nuclease P1 (5 μg) at 37 °C
for 1 h. Immediately after incubation, DNA solutions were spiked with
2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO, 5 μL, 1.5 M), 15N5-8-
oxo-dGuo (500 fmol), and 15N5-1,N
6-εdAdo (20 fmol) followed by
addition of NaOAc buffer II (sodium acetate 30 mM, pH 8.1), alkaline
phosphatase (20 units), and phosphodiesterase (0.012 units) then
incubated at 37 °C for an additional hour. Enzymes and undigested
DNA were removed by Microcon-10 filtration (11500 rpm, 4 °C, 50
min), and the filtrate was concentrated using a SpeedVac.
Samples were enriched for 8-oxo-dGuo and 1,N6-εdAdo using an
Agilent 1200 HPLC system equipped with a Atlantis T3 column (5
μm, 4.6 mm × 150 mm).47 The nucleosides were monitored at 264
nm. The column was eluted at a flow rate of 1 mL/min at 30 °C with a
5−80% MeOH gradient in 10 mM ammonium acetate buffer as
follows: hold at 5% MeOH for 5 min, 5−10% MeOH over 5 min, 10−
20% MeOH over 10 min, 20−80% over 10 min; re-equilibrate at 5%
Figure 2. Chemical structures of PCB 126, TCDD, and PeCDF.
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for 5 min. 8-oxo-dGuo and 1,N6-εdAdo fractions were collected at 24−
26 min and 33−34 min, respectively.
AcrdGuo, 1,N2-εdGuo, M1dGuo, CrdGuo, and HNEdGuo
Assay. An assay similar to 8-oxo-dGuo and 1,N6-εdAdo was applied
to measure AcrdGuo, 1,N2-εdGuo, M1dGuo, CrdGuo, and HNEdGuo
with minor modifications. Considering their similar chromatography
behaviors, these oxidation products were analyzed simultaneously. A
100 μg sample of DNA in NaOAc buffer I was incubated with nuclease
P1 (5 μg) at 37 °C for 1 h. Immediately after incubation, DNA
solutions were spiked with TEMPO (5 μL, 1.5 M), 15N5−AcrdGuo
(50 fmol), 13C10-1,N
2-εdGuo (100 fmol), MDA modified internal
standard DNA corresponding to 400 fmol 15N5-M1dGuo,
15N5−
CrdGuo (50 fmol), and 15N5−HNEdGuo (50 fmol), followed by
addition of NaOAc buffer II, alkaline phosphate (20 units), and
phosphodiesterase (0.012 units) then incubated at 37 °C for an
additional hour.42 Enzymes and undigested DNA were removed by
Microcon-10 filtration (11 500 rpm, 4 °C, 50 min), and the filtrate was
concentrated using a SpeedVac.
Samples were enriched for AcrdGuo, 1,N2-εdGuo, and M1dGuo by
the same HPLC method as described for 8-oxo-dGuo and 1,N6-εdAdo
with a 100% methanol and 5 mM ammonium formate−0.1% formic
acid gradient.47 CrdGuo and HNEdGuo were eluted at a flow rate of
0.5 mL/min, with a 35−70% MeOH gradient in 10 mM ammonium
acetate buffer over 25 min. Fraction collection times for AcrdGuo,
1,N2-εdGuo, CrdG, and HNEdGuo were 28−30 min, 32−34 min, 15−
18 min, and 34−36 min, respectively. All fractions of the enzyme-
digestion, MDA-treated DNA were collected every minute from the
HPLC. Following concentration via SpeedVac the fraction containing
M1dGuo was determined by using nanoLC−MS/MS.
42
N2,3-εG and 7-OEG Assay. N2,3-εG and 7-OEG were analyzed as
described previously by Mutlu et al.9,46
LC−MS/MS Analysis. 8-Oxo-dGuo was analyzed by a Waters
Acquity UPLC coupled to a Thermofinnigan TSQ Quantum Ultra
triple-quadrupole mass spectrometer in a positive selected reaction
mode (SRM) monitoring the signals m/z 284.1 → 168.0 for 8-oxo-
dGuo and m/z 289.1 → 173.0 for 15N5-8-oxo-dGuo. Separation was
performed on a T3 HSS column (1.7 μm, 2.1 mm × 100 mm) with a
flow rate of 200 μL/min using gradient (A) 0.1% acetic acid in water
and (B) 0.1% acetic acid in methanol. MS settings were as follows:
electrospray voltage (3000 V), ion transfer capillary temperature (285
°C), the vaporizer temperature (250 °C), sheath and auxiliary gas
pressures (35 and 30 arbitrary units), and collision energy (12 eV).
1,N6-εdAdo, AcrdGuo, 1,N2-εdGuo, M1dGuo, CrdGuo, and
HNEdGuo were analyzed by nanoAcquity UPLC coupled to a
Thermofinnigan TSQ Quantum Ultra triple-quadrupole mass
spectrometer in positive SRM monitoring the signals m/z 276.0 →
160.0 for 1,N6-εdAdo, m/z 281.0 → 165.0 for 15N5-1,N
6-εdAdo, m/z
304.0→ 188.0 for M1dGuo, m/z 309.0→ 193.0 for
15N5-M1dGuo, m/
z 292.0 → 176.0 for 1,N2-εdGuo, m/z 302.0 → 181.0 for 13C10-1,N
2-
εdGuo, m/z 424.0 → 308.0 for HNEdGuo, m/z 429.0 → 313.0 for
15N5-HNEdGuo, m/z 338.0→ 222.0 for CrdGuo, m/z 343.0→ 227.0
for 15N5-CrdGuo, m/z 324.0→ 208.0 for AcrdGuo, and m/z 329.0→
213.0 for 15N5-AcrdGuo. Separation was performed on a UPLC BEH
C18 column (1.7 μm, 100 μm × 100 mm) with a flow rate of 1 μL/
min using gradient (A) 5 mM ammonium formate in water and (B)
1% formic acid in acetonitrile for 1,N6-εdAdo, or (A) 0.1% formic acid
in water and (B) acetonitrile for AcrdGuo, 1,N2-εdGuo, M1dGuo,
CrdGuo, and HNEdGuo. MS settings were as follows: emitter tip
voltage (1500 V), ion transfer capillary temperature (285 °C), and
collision energy (12 eV).
Statistical Analysis. Statistical analyses were performed using R
(2.11). Considering the limited sample size in certain groups, the
nonparametric test was used to assess the differences between control
and PHAH-treated rats or various control groups for the number of
DNA oxidation products by Wilcox Rank Sum test. Two-sided and
one-sided p-values were considered significant if they were less than
0.05.
■ RESULTS AND DISCUSSION
In this study, we examined the relationship between exposure
to either TCDD or the tertiary mixture of TCDD, PCB 126,
and PeCDF and the formation of DNA oxidation products.
Female Sprague−Dawley rats were exposed to 0 and 100 ng/
Table 1. Number of 8-Oxo-dGuo Adducts/106 dGuo and 1,N6- εdAdo Adducts/108 dAdo Measured in Female Sprague−Dawley
Rat Hepatic DNA Following Exposure to TCDD (100 ng/kg/day) or the Tertiary Mixture of TCDD, PCB 126, and PeCDF
(TEQ 100 ng/kg/day) for 14, 31, and 53 Weeks
TCDD tertiary
14 weeks 31 weeks 53 weeks 14 weeks 31 weeks 53 weeks
8-oxo-dGuo add/106 dGuo control 2.41 ± 1.28 2.44 ± 0.80 3.20 ± 0.67 2.09 ± 0.75 2.54 ± 0.76 2.81 ± 0.49
exposeda 2.55 ± 0.91 2.72 ± 0.88 3.87 ± 0.47 3.93 ± 1.27c 4.06 ± 1.56c 4.87 ± 0.81b
1,N6-εdAdo add/108 dAdo control 1.47 ± 0.65 1.32 ± 0.44 0.91 ± 0.48 1.36 ± 0.32 1.31 ± 0.63 0.93 ± 0.56
exposeda 1.56 ± 0.23 2.76 ± 1.07b 2.13 ± 0.52c 2.75 ± 1.37c 6.55 ± 3.34c 4.13 ± 0.87c
aIndicates the exposures of TCDD, 100 ng/kg/day, and tertiary mixture (TCDD + PCB 126 + PeCDF), TEQ 100 ng/kg/day. bIndicates p ≤ 0.05
compared to corresponding control groups. cIndicates p ≤ 0.01 compared to corresponding control groups.
Table 2. Number of N2,3-εG Adducts/108 G, 7-OEG Adducts/107 G, 8-Oxo-dGuo Adducts/106 dGuo, and 1,N6- εdAdo
Adducts/108 dAdo Measured in Female Sprague−Dawley Rat Hepatic DNA Following Exposure to Multiple Concentrations of
TCDD or the Tertiary Mixture of TCDD, PCB 126, and PeCDF for 53 Weeks
N2,3-εG add/
108 G
7-OEG add/
107 G
8-oxo-dGuo add/
106 dGuo
1,N6-εdAdo add/
108 dAdo
TCDD 53 weeks control 2.18 ± 0.44 4.92 ± 1.07 3.20 ± 0.67 1.19 ± 0.39
22 ng/kg 2.55 ± 0.37 6.96 ± 0.81 3.34 ± 0.62 2.37 ± 0.84b
46 ng/kg 2.11 ± 0.56 7.47 ± 5.96 4.32 ± 0.14 2.51 ± 0.83b
100 ng/kg 4.44 ± 2.04a 29.8 ± 16.47b 3.87 ± 0.47 2.13 ± 0.52a
tertiary (TCDD+PCB 126+ PeCDF) 53 weeks control 2.07 ± 1.15 7.88 ± 3.77 2.81 ± 0.49 0.93 ± 0.56
22 ng/kgc 1.78 ± 0.19 7.81 ± 2.96 3.07 ± 0.11 3.93 ± 1.15b
46 ng/kgc 2.41 ± 1.04 9.92 ± 7.22 4.11 ± 0.60a 4.94 ± 1.63b
100 ng/kgc 2.55 ± 0.37 22.4 ± 14.84a 4.87 ± 0.80a 4.13 ± 0.87b
aIndicates p ≤ 0.05 compared to corresponding control groups. bIndicates p ≤ 0.01 compared to corresponding control groups. cIndicates TEQ
dose.
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kg/day of TCDD or TEQ doses of 0 and 100 ng/kg/day of the
tertiary mixture for 14, 31, and 53 weeks and to 0, 22, 46, and
100 ng/kg/day TCDD or TEQ doses of 0, 22, 46, and 100 ng/
kg/day of the tertiary mixture for 53 weeks.
Measurements of 8-oxo-dGuo and 1,N6-εdAdo formation in
the liver of the female rats exposed to TCDD (0 and 100 ng/
kg/day) or the tertiary mixture (TEQ 0, and 100 ng/kg/day) at
14, 31, and 53 weeks are shown in Table 1. While no significant
increase of 8-oxo-dGuo was detected after TCDD exposure for
14, 31, or 53 weeks, 1,N6-εdAdo concentrations for 31 (p =
0.03) and 53 (p = 0.003) weeks were higher in comparison to
their respective control groups. Exposure to the tertiary mixture
for 14 (p = 0.004 for 8-oxo-dGuo, and p = 0.004 for 1,N6-
εdAdo), 31 (p = 0.0001 for 8-oxo-dGuo, and p = 0.0002 for
1,N6-εdA), and 53 weeks (p = 0.02 for 8-oxo-dGuo, and p =
0.0002 for 1,N6-εdAdo) all showed statistically significant
increases in 8-oxo-dGuo and 1,N6-εdAdo. These increases
correspond to a 1.5−1.8-fold increase in 8-oxo-dGuo and a
1.5−5.0-fold increase in 1,N6-εdAdo in the hepatic DNA of
female rats.
The accumulations of N2,3-εG, 7-OEG, 8-oxo-dGuo, and
1,N6-εdAdo were evaluated in the hepatic DNA of the female
Sprague−Dawley Rats exposed to TCDD at 0, 22, 46, 100 ng/
kg/day or the tertiary mixture at TEQ doses of 0, 22, 46, 100
ng/kg/day for 53 weeks (Table 2). No accumulation of 8-oxo-
dGuo was observed after TCDD exposure, but a significant
increase of 8-oxo-dGuo was observed following exposure to the
tertiary mixture at TEQ doses of 46 (p = 0.03) and 100 ng/kg/
day (p = 0.02). 1,N6-εdAdo concentrations increased
significantly at all doses (22, 46, 100 mg/kg/day) following
either TCDD (p = 0.008, p = 0.008, and p = 0.02, respectively)
or tertiary (p = 0.003, p = 0.003, and p = 0.002, respectively)
exposures. Table 2 shows the significant increase in the number
of 7-OEG in the liver at the highest dose exposures of both
TCDD (100 ng/kg, p = 0.0098) and the tertiary mixture (TEQ
100 ng/kg, p = 0.014). Endogenous 7-OEG was measured to be
4.92 ± 1.07 adducts/107G in control samples, while exposure
to 100 ng/kg/day TCDD induced 29.79 ± 16.47 adducts/107G
of 7-OEG. Additionally, a three-fold increase was observed in 7-
OEG formation from exposure to the tertiary mixture. No
significant increase was observed for N2,3-εG concentration
after exposure to the tertiary mixture, including the highest
TEQ dose group, while a two-fold increase in N2,3-εG was
observed after 100 ng/kg/day TCDD exposure (p = 0.015).
Several other LPO-induced DNA products (1,N2-εdGuo;
M1dGuo; CrdGuo; HNEdGuo; AcrdGuo) were analyzed in the
hepatic DNA of female rats exposed to TCDD (100 ng/kg/
day) and the tertiary mixture (TEQ 100 ng/kg/day) for 53
Table 3. Number of 1,N2-εdGuo Adducts/108 dGuo,
M1dGuo adducts/10
8 dGuo, CrdGuo Adducts/108 dGuo,
HNEdGuo Adducts/108 dGuo, and AcrdGuo Adducts/108
dGuo Measured in Female Sprague−Dawley Rat Hepatic
DNA Following Exposure to TCDD (100 ng/kg/day) or the
Tertiary Mixture of TCDD, PCB 126, and PeCDF (TEQ 100
ng/kg/day) for 53 Weeks
TCDD add/108 dGuo tertiary add/108 dGuo
1,N2-εdGuo control 1.61 ± 0.37 2.07 ± 0.43
1,N2-εdGuo exposeda 2.14 ± 0.51 3.80 ± 1.12c
M1dGuo control 4.16 ± 1.02 4.71 ± 2.23
M1dGuo exposed
a 6.43 ± 1.68 12.4 ± 6.73b
CrdGuo control 0.24 ± 0.10 0.35 ± 0.07
CrdGuo exposeda 0.24 ± 0.06 0.50 ± 0.12b
HNEdGuo control 1.12 ± 0.05 0.90 ± 0.22
HNEdGuo exposeda 1.18 ± 0.38 1.40 ± 0.38
AcrdGuo control 6.02 ± 1.30 8.26 ± 0.98
AcrdGuo exposeda 7.16 ± 0.84 42.9 ± 24.50b
aIndicates the exposures of TCDD, 100 ng/kg/day, and tertiary
mixture (TCDD + PCB 126 + PeCDF), TEQ 100 ng/kg/day, 53
weeks. bIndicates p ≤ 0.05 compared to corresponding control groups.
cIndicates p ≤ 0.01 compared to corresponding control groups.
Figure 3. (Top) Cell proliferation in the liver of female Sprague−
Dawley rats exposed to TCDD (100 ng/kg/day) or the tertiary
mixture of TCDD, PCB 126, and PeCDF (TEQ 100 ng/kg/day) at
14, 31, and 53 weeks.21,24 (Bottom) Cell proliferation in the liver of
female Sprague−Dawley rats exposed to TCDD (0, 22, 46, and 100
ng/kg/day) or the tertiary mixture of TCDD, PCB 126, and PeCDF
(TEQ 0, 22, 46, and 100 ng/kg/day) at 53 weeks.21,24 ∗, Significantly
different (p ≤ 0.05) from the vehicle control group by Shirley’s test.
Figure 4. Tumor incidence from 2-year cancer bioassay of female
Sprague−Dawley rat livers exposed to TCDD (0, 22, 46, and 100 ng/
kg/day) or the tertiary mixture of TCDD, PCB 126, and PeCDF
(TEQ 0, 22, 46, and 100 ng/kg/day).21,24
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weeks (Table 3). Concentrations of 1,N2-εdGuo (p = 0.008),
M1dGuo (p = 0.03), CrdGuo (p = 0.05), and AcrdGuo (p =
0.03) were significantly higher in animals exposed to the
tertiary mixture, while no significant increase was observed in
any of the LPO-induced product concentrations in animals that
were exposed to TCDD (100 ng/kg/day) for 53 weeks.
As one of the predominant nongenotoxic pollutants in the
environment, the mechanism of PHAH-related carcinogenesis
has been studied for decades. Among them, TCDD is the most
researched. DNA oxidation products and oxidative stress
induced by TCDD have been measured extensively both in
vitro and in vivo.18,19,26−31 Hassoun et al. reported the
induction of LPO in the liver of female Sprague−Dawley rats
exposed to TCDD (100 ng/kg/day) for 13 and 30 weeks.27,29
LPO became more pronounced with increasing exposure time,
which is similar to our results for 1,N6-εdAdo (Table 1). In our
study, no significant increase of 1,N6-εdAdo was observed in
TCDD treated animals at 14-week exposure, but a two-fold
significant increase of this product was detected at 31 weeks
exposure. In the study by Hassoun et al., higher increases of
LPO were detected in animals exposed to TCDD for 30 weeks
(6-fold) than 13 weeks (1.5-fold).26 Similarly, DNA oxidation
product results found in our study showed statistically
significant increases (7-OEG, p = 0.00008; N2,3-εG, p =
0.0025; 1,N6-εdAdo, p = 0.0016) following 53-week exposure
to TCDD, which are shown in Table 2. Although an increase of
hepatic 8-oxo-dGuo was previously reported to be gender and
estrogen dependent in a two-stage carcinogenesis model with
diethylnitrosamine as initiator and TCDD as promotor,18 we
observed no significant induction of 8-oxo-dGuo in the female
rat livers following exposure to TCDD for 14, 31, or 53 weeks
(Table 1). These results may be due to differences between the
animal study designs or the analytical assays (LC−MS/MS vs
LC-ECD).18
Induction of superoxide anions, LPO and DNA single-strand
breaks following exposure to the tertiary mixture (TEQ 100
ng/kg/day) for 13 and 30 weeks in female rats was also
previously reported by Hassoun et al.26,29 In their study,
exposure for 30 weeks to the tertiary mixture induced more
superoxide anions and LPO (8.2-fold, 2.3-fold) than 13 week
exposure (6-fold, 1.9-fold), which indicated that production of
these biomarkers is time-dependent.26,29 Consistently, more
DNA oxidation products were induced in liver DNA of our
studied animals after exposure to the tertiary mixture for 31
weeks than 14 weeks, as indicated by 1,N6-εdAdo and 8-oxo-
dGuo results in Table 1. Significant dose-dependent increases
in the production of superoxide anions, LPO and DNA single-
strand breaks in the liver of female rats were also reported in
the liver DNA of female rats exposed to the tertiary mixture for
13 weeks and 30 weeks in Hassoun et al.’s studies.26,29
Consistently, we found a significant positive association
between exposure dose and concentrations of 7-OEG (p <
0.05), 8-oxo-dGuo (p = 0.00041), and 1,N6-εdAdo (p < 1 ×
10−5) following exposure to the tertiary mixture for 53 weeks
(Table 2).
Similar to other toxic effects of TCDD, DNA oxidation
damage and oxidative stress have been assumed to be
connected with the AhR and activation of cytochrome P450
superfamily of enzymes, especially CYP1A1.37,38 The upregu-
lation of these enzymes triggers metabolic changes of
endogenous compounds in vivo, which may further produce
DNA oxidation damage. Since the TEF methodology is based
on the AhR affinity of PHAHs and oxidative stress was reported
in diverse biological systems exposed to PHAHs, the TEF
methodology may also be valuable for the evaluation of
oxidative stress and oxidative damage induced by mixtures of
PHAHs, especially DLCs. However, the DNA oxidation
product findings in this study, and several other studies,
indicate that a simple TEF value cannot be applied to evaluate
oxidative stress and oxidative damage.26,48 Hassoun et al.
showed that following 13-weeks exposure, higher levels of
superoxide anions and LPO were induced in the liver of female
rats exposed to the tertiary mixture (TEQ 100 ng/kg/day) than
TCDD alone (100 ng/kg/day).26 With similar background
concentrations in control samples, the concentrations of
superoxide anion were ∼1.3 and 0.4 nmol cytochrome c
reduced/mg in the animals treated with the tertiary mixture or
TCDD alone, respectively. The concentrations of LPO were
∼3 and 2 nmol 2-thiobarbituric acid substances (TBARS)
formed/mg protein detected in these two groups, respec-
tively.26,27 Additionally, synergistic effects of TCDD, PeCDF,
and PCB126 were indicated in the production of superoxide
anion in hepatic tissues, which required only 0.25−0.5% of the
doses of the three individual congeners within the tertiary
mixture to produce similar effects for each congener alone.26
The interactions of these three congeners were also seen in the
process of superoxide anion production in female rats exposed
to the tertiary mixture for 30 weeks.29 A significant difference
was observed when comparing the dose−response curves of
superoxide anion production in the hepatic tissues exposed to
the tertiary mixture versus TCDD, PeCDF or PCB126 alone,
with larger effects produced by an equivalent dose of the
tertiary mixture than the three congeners alone.
In our study, we compared oxidation DNA product
formation induced by either TCDD (100 ng/kg/day) or the
tertiary mixture (TEQ 100 ng/kg/day) for 14, 31, and 53
weeks. A significant production of hepatic 8-oxo-dGuo and
1,N6-εdAdo was observed following exposure to the tertiary
mixture at all time points, while TCDD-exposed animals
showed a significant increase in 1,N6-εdAdo (31 and 53 weeks)
but no significant difference in 8-oxo-dGuo. After 53-week
exposure, significant induction of 1,N2-εdGuo, M1dGuo,
AcrdGuo, and CrdGuo was observed in the tertiary mixture-
treated rat liver DNA; however, none of the products showed
significant changes in TCDD-treated animals. Conversely, a
significant induction of 7-OEG and N2,3-εG was observed in
the liver following 53-week exposure to TCDD, while only 7-
OEG was significantly induced in tertiary mixture-exposed
animals, as indicated in Table 2.
Complex results were also reported in the toxicogenomic
analysis by Vezina et al.48 and Ovando et al.49 Vezina et al.
examined the gene expression in the hepatic DNA of female
rats exposed to TCDD, PCB 126, and PeCDF for 14 weeks.48
With the same TEQ dose used in this study (100 ng/kg/day), a
limited subset of genes, which included CAT, cytochrome b5
(CYPB5), and COX oxidative stress response genes, was
activated by PeCDF and PCB 126 alone, but not TCDD.
PeCDF and PCB 126 also induced growth arrest and a DNA-
damage-inducible gene product, Gadd45, indicating oxidative
DNA damage in the liver from those animals exposed to these
chemicals. Interestingly, Gadd45 was not induced in TCDD-
treated animals. Therefore, PeCDF and PCB126 were more
effective in activating the expression of oxidative stress response
genes than TCDD in the liver of these animals after a 14-week
exposure. Similar genomic studies were conducted in the
hepatic tissue of female rats following 53-week exposure to
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TCDD and PCB126 by Ovando et al.49 A dose-dependent
increase in the number of differentially expressed genes was
observed in animals exposed to PCB 126 for 53 weeks with 30,
300, and 1000 ng/kg/day. While fewer genes were differentially
expressed in animals exposed to PCB 126 for 53 weeks (216)
than 13 weeks (371), many more genes showed differential
expression in animals exposed to TCDD for 53 weeks (299)
than 13 weeks (103) with the same TEQ dose. More ROS or
their active metabolite-related detoxification genes were
upregulated or downregulated in the chronic TCDD exposed
animals including glutathione-S-transferase (GST), glutathione
peroxidase, aldehyde dehydrogenase (Aldh), and aldo-keto
reductase (Akr).
DNA oxidation damage in rodents exposed to DLCs is
probably induced through upregulation of cytochrome P450
superfamily of enzymes, mediated by AhR-dependent path-
ways.37,38 The dose−response and different time course
induction of CYP1A1 is well characterized in the liver of
female Sprague−Dawley rats following exposure to TCDD and
the tertiary mixture21,24,50 CYP1A1 induction occurs in virtually
every tissue of the body following exposure to either TCDD or
the tertiary mixture.21,24 By using the continuous nonlinear Hill
model, the induction of hepatic CYP1A1 was compared in
female rats following exposure to TCDD, PCB 126, and
PeCDF alone or their tertiary mixture with doses or TEQ doses
ranging from 0−100 ng/kg/day for 14, 31, or 53 weeks.50 The
estimated parameters indicated that congener-specific dose−
response shapes were significantly different, and the additivity
of TEF methodology failed for these individual congeners and
their mixture. Six of the 12 equiv time-dose combinations failed
to agree between the tertiary mixture and TCDD alone. The
same results were found when liver concentrations of TCDD or
TEQ dose for the tertiary mixture were used. The maximum
activity of 7-ethoxyresorufin-o-deethylase (EROD) is substan-
tially higher (1.2−3.0-fold) for PeCDF than TCDD with the
same TEQ dose. Toyoshiba et al. observed significant,
nonadditive interaction for EROD activity at 31 and 53
weeks in the tertiary mixture exposed samples but not at 14
weeks.50 In summary, although the importance of CYP1A1 in
the induction of oxidative DNA damage was implied previously,
the complicated association between DNA oxidation damage
and induction of CYP1A1 by DLCs or their mixtures cannot be
completely described in our study and still requires further
detailed exploration. DNA oxidation products, oxidative stress
biomarkers, CYP1A1 induction, and genomic studies consis-
tently suggest that the simple TEF methodology cannot be
applied to evaluate the diverse patterns of toxic effects induced
by DLCs.
Mutation studies have suggested that oxidative stress and
DNA oxidation damage, especially from chronic inflammation,
are associated with carcinogenesis.2,3 At present, more than one
hundred DNA oxidation products are reported in model
studies, but less than 20 of them are measured in cellular
DNA.51 Among them, 8-oxo-dGuo is the most extensively
studied in vivo adduct with G to T transversions as the
dominant mutation pattern.8 Many assays have been developed
to detect this product in animal or human tissues,8,52 but
artificial formation during sample preparation has hampered its
application as a good biomarker.52,53 1,N6-εdAdo is another
popular biomarker, widely applied to evaluate chronic
inflammation and LPO in animal or human tissues.3 1,N6-
εdAdo, 1,N2-εdGuo, N2,3-εG, M1dGuo, AcrdGuo, CrdGuo,
and HNEdGuo can also induce distinct mutation spectra,
similar to 8-oxo-dGuo.10−12 However, compared with 1,N6-
εdAdo and 8-oxo-dGuo, the other products examined in our
study are less widely applied in risk assessment of carcinogens.
7-OEG, the predominant product formed by vinyl chloride in
rodents, was also recently established as an LPO-induced
product.9 Although it is not a direct promutagenic adduct, 7-
OEG can cause AP sites and further induce mutations if they
cannot be repaired before cell replication.54 In addition to
promutagenic properties, 8-oxo-dGuo, 1,N6-εdAdo, 1,N2-
εdGuo, N2,3-εG, M1dGuo, AcrdGuo, CrdGuo, and HNEdGuo
also have distinct metabolic pathways, as shown in Figure 1.
Furthermore, the primary repair pathways for these products
are also different.11,55−58 For small products (8-oxo-dGuo;
1,N6-εdAdo; 1,N2-εdGuo; N2,3-εG), base excision repair (BER)
is the dominant repair pathway, with different glycosylases
involved to repair different products.55−57,59 For the medium
and bulky products (AcrdGuo; CrdGuo; HNEdGuo;
M1dGuo), nuclear excision repair (NER) is the primary repair
pathway.11,58 Therefore, the simple concentration of a DNA
oxidation product in animals reflects the complex interactions
between environmental and biological systems. The potential
adverse effect of a product is dynamically controlled by its
formation and repair pathways, which could be determined by
numerous factors including, but not limited to, exposure dose,
exposure time, exposure pathway, chemical metabolism, tissue,
age, sex, and species. A corresponding mutation spectrum study
is still necessary for further validation of the biological
significance of certain DNA oxidation products in hepatic
toxicity of TCDD and the tertiary mixture exposed animals
examined in our study.
Besides the possible indirect genotoxicity of oxidative stress,
cytotoxicity, stimulation of cell proliferation, inhibition of
apoptosis, and induction of enzymes are all suggested to be
involved in the toxicity of TCDD and its congeners.60−63 As
depicted in Figure 3, hepatic cells from female rats showed a
high rate of proliferation following exposure to TCDD alone
(100 ng/kg/day) or the tertiary mixture (TEQ 100 ng/kg/day)
for 53 weeks, which is consistent with our DNA oxidation
product induction results in Tables 2 and 3. No significant
enhancement of cell proliferation was observed in 14-week
TCDD or tertiary mixture exposed animals, but it was observed
in 31- and 53-week TCDD and tertiary mixture exposed
animals.22,24 Low-dose exposure of TCDD or the tertiary
mixture for 53 weeks failed to induce significant production of
cell proliferation, which agreed with the observation of dose-
dependent accumulation of DNA oxidation products following
53-week exposure. Dose- and time-dependent induction of
CYP1A1 and CYP1A2 was detected in the livers of female rats
exposed to TCDD or the tertiary mixture, which is also in
accordance with our results of DNA oxidation products.21,24
Additionally, increased incidences and severities of hepatocyte
inflammation were observed at 31 and 53 weeks in TCDD or
the tertiary mixture exposed animals. All these factors are
potential players, which can be combined to induce the dose-
dependent incidence of hepatocellular adenoma and chol-
angiocarcinoma in the 2-year cancer bioassay by the NTP.21,24
Recent advances in scientific understanding of cancer biology
support the view that environmental chemicals can act through
multiple toxicity pathways, modes, or mechanisms of action to
induce cancer.64,65 However, evaluating the relative weight of
each possible important contributor to cancer induction is far
more complicated than simply identifying them. The role DNA
oxidation damage plays in the hepatic toxicity effect of PHAHs
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in female rats may be a good case in point. Although the 2-year
tumor incidence data (Figure 4) support the application of the
TEF approach in the risk assessment of DLCs based on the
generation of similar dose−response curves in response to
TCDD and the tertiary mixture exposed female rats,66 the TEF
approach cannot be applied to evaluate the DNA oxidation
products in this study, CYP1A1 or CYP1A2 induction, or
oxidative biomarkers.26,27,29,50 Such inconsistency further
indicates the complexity of the formation of DNA oxidation
damage and carcinogenesis of DLCs in the liver of female rats.
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